Tested Applications
| Positive WB detected in | LNCaP cells, U2OS cells, PC-3 cells |
| Positive IP detected in | LNCaP cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
27610-1-AP targets FBXO11 in WB, IP, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag24401 Product name: Recombinant human FBXO11 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 858-927 aa of BC012728 Sequence: TDRNAICVNCIKKCHQGHDVEFIRHDRFFCDCGAGTLSNPCTLAGEPTHDTDTLYDSAPPIESNTLQHN Predict reactive species |
| Full Name | F-box protein 11 |
| Calculated Molecular Weight | 927 aa, 104 kDa |
| Observed Molecular Weight | 94-104 kDa |
| GenBank Accession Number | BC012728 |
| Gene Symbol | FBXO11 |
| Gene ID (NCBI) | 80204 |
| RRID | AB_2880925 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q86XK2 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IP protocol for FBXO11 antibody 27610-1-AP | Download protocol |
| WB protocol for FBXO11 antibody 27610-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The FBXO11 Polyclonal antibody (27610-1-AP) has 4 total citations. It appears in the journals Phytomedicine (IF 11.3), Clin Transl Med (IF 7.9), Biochim Biophys Acta Mol Basis Dis (IF 5), and FEBS Open Bio (IF 2.7). The associated research fields include colorectal cancer progression, hepatocellular carcinoma (lipid metabolism reprogramming and stemness), and biliary atresia/liver fibrosis involving epithelial-mesenchymal transition.
| Species | Application | Title |
|---|---|---|
Phytomedicine FBXO11 enhances colorectal cancer progression through TMBIM6 stabilization: Echinacoside as a natural inhibitor. | ||
Clin Transl Med Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-boxFBXO11 -mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma
| ||
Biochim Biophys Acta Mol Basis Dis PRAG1 promotes cholangiocyte epithelial-mesenchymal transition and liver fibrosis in biliary atresia | ||
FEBS Open Bio The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail.
|





